We won't able to start phase 3 until we have completed final phase 2 study next Feb in 2022 and then approved by FDA say mid of next year. Someone can't wait for that long?
Phase 3 costs millions of millions I never thought we can afford it provided we have massive pipeline. Even the last CR was allocated just a little to Hervaxx only
I still believe Hervaxx was born to be sold before phase 3 and today's extended trial tells me that bigpham want to see more data with the best combination before writing us a big chq
Again we would to have more details on the extended trials like size, cost, length and whom
We won't able to start phase 3 until we have completed final...
-
- There are more pages in this discussion • 220 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.003(5.56%) |
Mkt cap ! $417.2M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.8¢ | 5.2¢ | $2.499M | 45.00M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1921794 | 5.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 1368288 | 7 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMU (ASX) Chart |